Human Vaccines Administered Orally and Forecast Market

List of Tables
Table 1. Key Players of Human Vaccines Administered Orally in Global Market
Table 2. Top Human Vaccines Administered Orally Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Human Vaccines Administered Orally Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Human Vaccines Administered Orally Revenue Share by Companies, 2018-2023
Table 5. Global Human Vaccines Administered Orally Sales by Companies, (K Units), 2018-2023
Table 6. Global Human Vaccines Administered Orally Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Human Vaccines Administered Orally Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Human Vaccines Administered Orally Product Type
Table 9. List of Global Tier 1 Human Vaccines Administered Orally Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Vaccines Administered Orally Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Human Vaccines Administered Orally Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Human Vaccines Administered Orally Sales (K Units), 2018-2023
Table 15. By Type - Global Human Vaccines Administered Orally Sales (K Units), 2024-2030
Table 16. By Application ? Global Human Vaccines Administered Orally Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Human Vaccines Administered Orally Sales (K Units), 2018-2023
Table 20. By Application - Global Human Vaccines Administered Orally Sales (K Units), 2024-2030
Table 21. By Region ? Global Human Vaccines Administered Orally Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Human Vaccines Administered Orally Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Human Vaccines Administered Orally Sales (K Units), 2018-2023
Table 25. By Region - Global Human Vaccines Administered Orally Sales (K Units), 2024-2030
Table 26. By Country - North America Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Human Vaccines Administered Orally Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Human Vaccines Administered Orally Sales, (K Units), 2018-2023
Table 29. By Country - North America Human Vaccines Administered Orally Sales, (K Units), 2024-2030
Table 30. By Country - Europe Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Human Vaccines Administered Orally Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Human Vaccines Administered Orally Sales, (K Units), 2018-2023
Table 33. By Country - Europe Human Vaccines Administered Orally Sales, (K Units), 2024-2030
Table 34. By Region - Asia Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Human Vaccines Administered Orally Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Human Vaccines Administered Orally Sales, (K Units), 2018-2023
Table 37. By Region - Asia Human Vaccines Administered Orally Sales, (K Units), 2024-2030
Table 38. By Country - South America Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Human Vaccines Administered Orally Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Human Vaccines Administered Orally Sales, (K Units), 2018-2023
Table 41. By Country - South America Human Vaccines Administered Orally Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Human Vaccines Administered Orally Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Human Vaccines Administered Orally Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Human Vaccines Administered Orally Sales, (K Units), 2024-2030
Table 46. Merck Company Summary
Table 47. Merck Human Vaccines Administered Orally Product Offerings
Table 48. Merck Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Merck Key News & Latest Developments
Table 50. GSK Company Summary
Table 51. GSK Human Vaccines Administered Orally Product Offerings
Table 52. GSK Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. GSK Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Human Vaccines Administered Orally Product Offerings
Table 56. Sanofi Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Lanzhou Institute Company Summary
Table 59. Lanzhou Institute Human Vaccines Administered Orally Product Offerings
Table 60. Lanzhou Institute Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Lanzhou Institute Key News & Latest Developments
Table 62. Serum Institute Company Summary
Table 63. Serum Institute Human Vaccines Administered Orally Product Offerings
Table 64. Serum Institute Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Serum Institute Key News & Latest Developments
Table 66. Valneva Company Summary
Table 67. Valneva Human Vaccines Administered Orally Product Offerings
Table 68. Valneva Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Valneva Key News & Latest Developments
Table 70. Shanghai United Cell Company Summary
Table 71. Shanghai United Cell Human Vaccines Administered Orally Product Offerings
Table 72. Shanghai United Cell Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Shanghai United Cell Key News & Latest Developments
Table 74. Bibcol Company Summary
Table 75. Bibcol Human Vaccines Administered Orally Product Offerings
Table 76. Bibcol Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Bibcol Key News & Latest Developments
Table 78. PaxVax Company Summary
Table 79. PaxVax Human Vaccines Administered Orally Product Offerings
Table 80. PaxVax Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. PaxVax Key News & Latest Developments
Table 82. Vabiotech Company Summary
Table 83. Vabiotech Human Vaccines Administered Orally Product Offerings
Table 84. Vabiotech Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Vabiotech Key News & Latest Developments
Table 86. Tiantan Biological Company Summary
Table 87. Tiantan Biological Human Vaccines Administered Orally Product Offerings
Table 88. Tiantan Biological Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Tiantan Biological Key News & Latest Developments
Table 90. EuBiologics Company Summary
Table 91. EuBiologics Human Vaccines Administered Orally Product Offerings
Table 92. EuBiologics Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. EuBiologics Key News & Latest Developments
Table 94. Panacea Biotec Ltd Company Summary
Table 95. Panacea Biotec Ltd Human Vaccines Administered Orally Product Offerings
Table 96. Panacea Biotec Ltd Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Panacea Biotec Ltd Key News & Latest Developments
Table 98. Bio-Med Company Summary
Table 99. Bio-Med Human Vaccines Administered Orally Product Offerings
Table 100. Bio-Med Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Bio-Med Key News & Latest Developments
Table 102. Halfkin Bio-Pharmaceuticals Company Summary
Table 103. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Product Offerings
Table 104. Halfkin Bio-Pharmaceuticals Human Vaccines Administered Orally Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Halfkin Bio-Pharmaceuticals Key News & Latest Developments
Table 106. Human Vaccines Administered Orally Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 107. Global Human Vaccines Administered Orally Capacity Market Share of Key Manufacturers, 2021-2023
Table 108. Global Human Vaccines Administered Orally Production by Region, 2018-2023 (K Units)
Table 109. Global Human Vaccines Administered Orally Production by Region, 2024-2030 (K Units)
Table 110. Human Vaccines Administered Orally Market Opportunities & Trends in Global Market
Table 111. Human Vaccines Administered Orally Market Drivers in Global Market
Table 112. Human Vaccines Administered Orally Market Restraints in Global Market
Table 113. Human Vaccines Administered Orally Raw Materials
Table 114. Human Vaccines Administered Orally Raw Materials Suppliers in Global Market
Table 115. Typical Human Vaccines Administered Orally Downstream
Table 116. Human Vaccines Administered Orally Downstream Clients in Global Market
Table 117. Human Vaccines Administered Orally Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Human Vaccines Administered Orally Segment by Type in 2022
Figure 2. Human Vaccines Administered Orally Segment by Application in 2022
Figure 3. Global Human Vaccines Administered Orally Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Vaccines Administered Orally Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Human Vaccines Administered Orally Revenue, 2018-2030 (US$, Mn)
Figure 7. Human Vaccines Administered Orally Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Human Vaccines Administered Orally Revenue in 2022
Figure 9. By Type - Global Human Vaccines Administered Orally Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Human Vaccines Administered Orally Revenue Market Share, 2018-2030
Figure 11. By Type - Global Human Vaccines Administered Orally Sales Market Share, 2018-2030
Figure 12. By Type - Global Human Vaccines Administered Orally Price (US$/Unit), 2018-2030
Figure 13. By Application - Global Human Vaccines Administered Orally Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Human Vaccines Administered Orally Revenue Market Share, 2018-2030
Figure 15. By Application - Global Human Vaccines Administered Orally Sales Market Share, 2018-2030
Figure 16. By Application - Global Human Vaccines Administered Orally Price (US$/Unit), 2018-2030
Figure 17. By Region - Global Human Vaccines Administered Orally Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Human Vaccines Administered Orally Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Human Vaccines Administered Orally Revenue Market Share, 2018-2030
Figure 20. By Region - Global Human Vaccines Administered Orally Sales Market Share, 2018-2030
Figure 21. By Country - North America Human Vaccines Administered Orally Revenue Market Share, 2018-2030
Figure 22. By Country - North America Human Vaccines Administered Orally Sales Market Share, 2018-2030
Figure 23. US Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Human Vaccines Administered Orally Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Human Vaccines Administered Orally Sales Market Share, 2018-2030
Figure 28. Germany Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 29. France Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Human Vaccines Administered Orally Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Human Vaccines Administered Orally Sales Market Share, 2018-2030
Figure 37. China Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 41. India Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Human Vaccines Administered Orally Revenue Market Share, 2018-2030
Figure 43. By Country - South America Human Vaccines Administered Orally Sales Market Share, 2018-2030
Figure 44. Brazil Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Human Vaccines Administered Orally Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Human Vaccines Administered Orally Sales Market Share, 2018-2030
Figure 48. Turkey Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Human Vaccines Administered Orally Revenue, (US$, Mn), 2018-2030
Figure 52. Global Human Vaccines Administered Orally Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Human Vaccines Administered Orally by Region, 2022 VS 2030
Figure 54. Human Vaccines Administered Orally Industry Value Chain
Figure 55. Marketing Channels